SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEvoke Plc Regulatory News (EVOK)

Share Price Information for Evoke Plc (EVOK)

Share Price is delayed by 15 minutes
Get Live Data
46.20    -0.55 (-1.18%)
Bid:
46.30
Ask:
46.50
Spread: 0.20 (0.432%)
Market Cap: £207.96m
EVOK Live PriceLast checked at - London Stock Exchange

Intraday Evoke Plc Share Chart

2025 Post-close Trading Update

27 Jan 2026 07:00

RNS Number : 4426Q
Evoke PLC
27 January 2026
 

 

27 January 2026

 

evoke Plc

("evoke" or "the Group")

 

2025 Post-close Trading Update

FY25 revenue growth of +2%; FY25 Adjusted EBITDA expected to be in line with market expectations

evoke (LSE: EVOK), one of the world's leading betting and gaming companies with internationally renowned brands including William Hill, 888 and Mr Green, today announces a post-close trading update for the three and 12 months ending 31 December 2025 ("Q4" and "FY25" respectively).

Financial performance

Q4 revenue was approximately £464m, representing the strongest quarter of the year. Q4 revenue was up 7% quarter-over-quarter ("QoQ"), but down 3% (4% in constant currency) year-over-year ("YoY") as a result of the strong comparative period with operator friendly sporting results in the prior year.

The improved Q4 performance was driven by gaming (+9% YoY), which saw growth across all divisions, including 888casino returning to growth in the UK and strong growth in both Retail (+10% YoY) and International (+14% YoY). Betting revenue was down 22% YoY for the Group due to the strong prior year comparative.

As a result, revenue for FY25 is expected to be approximately £1,786m (+2% YoY). Reflecting the Group's focus on achieving profitable growth and the successful delivery of cost savings through the year, Adjusted EBITDA is expected to be in the range of £355-360m (approximately 14-15% higher YoY). This would be in line with market expectations and would represent an Adjusted EBITDA Margin of approximately 20%, in line with prior guidance.

Strategic review and outlook

As previously announced on 10 December 2025, the Board is undertaking a review of the Company's strategic options, including the consideration of a range of potential alternatives to maximise shareholder value. This includes, but is not limited to, a potential sale of the Group, or some of the Group's assets and/or business units. Accordingly, while this review remains ongoing the Board does not consider it appropriate to provide forward-looking financial guidance at this time. The Group will update the market on the progress of the strategic review when and if appropriate and will issue its full year results in due course.

Per Widerström, CEO of evoke, commented:

"During Q4 we made good progress against our strategic plans, delivering our best quarter of the year and demonstrating the underlying momentum in the business. Our focus on core markets continued to drive our profitable growth, with Italy and Denmark both delivering record quarterly revenues in Q4. This positive momentum has continued into 2026 with a strong start to the year with good growth across all divisions.

While the strong strategic and financial progress we made throughout 2025 was encouraging, we were very disappointed with the outcome of the UK Budget in November that dealt a significant blow to both evoke and the wider regulated industry. We continue to believe these tax increases will negatively impact the industry's economic contribution, customer protection, and will ultimately serve to support further growth in the illegal black market. As a result of these significant UK tax increases, the Board is assessing its strategic options, with a resolute focus on maximising shareholder value.

We have moved quickly and decisively to execute on our mitigation plans including the closure of retail stores that are no longer sustainable as well as broader cost savings, and we will update shareholders on our progress and updated strategic plan in due course."

 

Enquiries and further information:

evoke Plc

+44(0) 800 029 3050

Per Widerström, CEO

Sean Wilkins, CFO

 

Investor Relations

James Finney, Director of IR

 

Media

 

ir@evokeplc.com

 

 

evoke@hudsonsandler.com

Hudson Sandler

Alex Brennan / Hattie Dreyfus / Andy Richards

+44(0) 207 796 4133

 

About evoke Plc:

evoke plc (and together with its subsidiaries, "evoke" or the "Group") is one of the world's leading betting and gaming companies. The Group owns and operates internationally renowned brands including William Hill, 888, and Mr Green. Incorporated in Gibraltar, and headquartered and listed in London, the Group operates from offices around the world.

The Group's vision is to make life more interesting and its mission is to delight players with world-class betting and gaming experiences.

Find out more at: https://www.evokeplc.com

 

Important Notices

This announcement may contain certain forward-looking statements, beliefs or opinions, with respect to the financial condition, results of operations and business of evoke. These statements, which contain the words "anticipate", "believe", "intend", "estimate", "expect", "may", "will", "seek", "continue", "aim", "target", "projected", "plan", "goal", "achieve", words of similar meaning or other forward looking statements, reflect evoke's beliefs and expectations and are based on numerous assumptions regarding evoke's present and future business strategies and the environment evoke will operate in and are subject to risks and uncertainties that may cause actual results to differ materially. No representation is made that any of these statements or forecasts will come to pass or that any forecast results will be achieved. Forward-looking statements involve inherent known and unknown risks, uncertainties and contingencies because they relate to events and depend on circumstances that may or may not occur in the future and may cause the actual results, performance or achievements of evoke to be materially different from those expressed or implied by such forward looking statements. Many of these risks and uncertainties relate to factors that are beyond evoke's ability to control or estimate precisely, such as future market conditions, currency fluctuations, the behaviour of other market participants, the actions of regulators and other factors such as evoke's ability to continue to obtain financing to meet its liquidity needs, changes in the political, social and regulatory framework in which evoke operates or in economic or technological trends or conditions. Past performance of evoke cannot be relied on as a guide to future performance. As a result, you are cautioned not to place undue reliance on such forward-looking statements. The list above is not exhaustive and there are other factors that may cause evoke's actual results to differ materially from the forward-looking statements contained in this announcement. Forward-looking statements speak only as of their date and evoke, its respective parent and subsidiary undertakings, the subsidiary undertakings of such parent undertakings, and any of such person's respective directors, officers, employees, agents, affiliates or advisers expressly disclaim any obligation to supplement, amend, update or revise any of the forward-looking statements made herein, except where it would be required to do so under applicable law. No statement in this announcement is intended as a profit forecast or a profit estimate and no statement in this announcement should be interpreted to mean that the financial performance of evoke for the current or future financial years would necessarily match or exceed the historical published for evoke.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBFMMTMTATTAF
Date   Source Headline
12th Jun 20263:48 pmRNSAwards granted under the LTIP
9th Jun 20263:30 pmRNSNotification of Transactions by PDMR
8th Jun 202612:18 pmRNSResults of AGM 8 June 2026
5th Jun 20267:00 amRNSRecommended all-share acquisition of evoke plc
4th Jun 20265:55 pmRNSHolding(s) in Company
1st Jun 20267:00 amRNSTotal Voting Rights
18th May 20264:35 pmRNSExtension of Firm Offer Deadline
11th May 20267:00 amRNSPublication of Notice of AGM
1st May 20267:00 amRNSTotal Voting Rights & Correction
30th Apr 20267:00 amRNSFY25 Results
28th Apr 20262:11 pmRNSDelay to publication of FY25 audited results
20th Apr 20267:01 amRNSStatement regarding media speculation
14th Apr 20267:00 amRNSBlock Listing Six Monthly Return
1st Apr 20269:56 amRNSTotal Voting Rights
31st Mar 202612:34 pmRNSHolding(s) in Company
18th Mar 20267:00 amRNSNotice of FY25 Results
2nd Mar 20267:00 amRNSTotal Voting Rights
2nd Feb 20267:00 amRNSTotal Voting Rights
27th Jan 20267:00 amRNS2025 Post-close Trading Update
2nd Jan 20267:00 amRNSTotal Voting Rights
2nd Jan 20267:00 amRNSTotal Voting Rights
18th Dec 20257:00 amRNSNotice of FY 2025 Trading Update
17th Dec 20254:40 pmRNSHolding(s) in Company
10th Dec 202510:53 amRNSStrategic Review
1st Dec 20257:00 amRNSTotal Voting Rights
26th Nov 20255:45 pmRNSResponse to the UK Budget
3rd Nov 20257:00 amRNSTotal Voting Rights
28th Oct 20257:00 amRNSQ3 2025 trading update
21st Oct 20257:00 amRNSBoard Change
14th Oct 20257:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
7th Oct 20257:00 amRNSCommittee Update
1st Oct 20257:00 amRNSTotal Voting Rights
25th Sep 20257:00 amRNSNotice of Q3 2025 trading update
11th Sep 20257:00 amRNSPricing of an offering of Senior Secured Notes
1st Sep 20257:00 amRNSTotal Voting Rights
13th Aug 20257:00 amRNSH1 2025 Interim Results
4th Aug 20257:00 amRNSInvestor Meet Company Presentation
1st Aug 20257:00 amRNSTotal Voting Rights
22nd Jul 20257:00 amRNSH1 2025 Post-Close Trading Update
16th Jul 20257:00 amRNSNotice of H1 2025 trading update
1st Jul 20257:00 amRNSTotal Voting Rights
26th Jun 20257:00 amRNSDirector Declaration
18th Jun 20258:28 amRNSDirector Declaration
2nd Jun 20257:00 amRNSTotal Voting Rights
28th May 202512:36 pmRNSResults of AGM 28 May 2025
28th May 20257:00 amRNSEstablishment of a Technology Committee
27th May 20255:39 pmRNSPurchase of Annual Bonus shares
1st May 20257:00 amRNSTotal Voting Rights
30th Apr 20255:53 pmRNSNotification of Transactions by PDMR
25th Apr 20258:00 amRNSNotice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.